About
BioExoTec develops minimally invasive diagnostic tests for early cancer detection by analyzing tumor-specific molecular signatures in extracellular vesicles from blood and saliva samples.
Explore BioExoTec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.